Subcutaneous immunotherapy (DPT-sensitized)

· Roxall Medicina España S.A

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Subcutaneous immunotherapy (DPT-sensitized), covering 2019-05-06 to 2019-05-06. Get the full timeline:

Most recent: Clinical Trial Update: Subcutaneous Immunotherapy in Patients Sensitized to Dermatophagoides Pteronyssinus (DPT) [Phase 1]